1. Home
  2. GKOS vs ENS Comparison

GKOS vs ENS Comparison

Compare GKOS & ENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$119.43

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo EnerSys

ENS

EnerSys

HOLD

Current Price

$184.05

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
ENS
Founded
1998
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
ENS
Price
$119.43
$184.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
3
Target Price
$132.00
$175.00
AVG Volume (30 Days)
847.6K
388.8K
Earning Date
02-17-2026
02-04-2026
Dividend Yield
N/A
0.58%
EPS Growth
N/A
21.73
EPS
N/A
8.58
Revenue
$469,820,000.00
$3,725,304,000.00
Revenue This Year
$32.39
$4.38
Revenue Next Year
$23.05
$2.83
P/E Ratio
N/A
$21.09
Revenue Growth
30.38
6.17
52 Week Low
$73.16
$76.57
52 Week High
$161.78
$181.26

Technical Indicators

Market Signals
Indicator
GKOS
ENS
Relative Strength Index (RSI) 54.11 80.94
Support Level $116.73 $172.40
Resistance Level $128.84 $177.47
Average True Range (ATR) 6.18 4.70
MACD 0.07 1.33
Stochastic Oscillator 70.18 94.02

Price Performance

Historical Comparison
GKOS
ENS

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

Share on Social Networks: